Geode Capital Management
ANAC

Geode Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Geode Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-312,998
Closed -$16.7K – 4180
2016
Q1 		$16.7K Buy
312,998
+15,243
+5% +$1.13M 0.01% 1035
2015
Q4 		$33.6M Sell
297,755
-937
-0.3% -$103K 0.02% 659
2015
Q3 		$35.2M Buy
298,692
+421
+0.1% +$55K 0.02% 626
2015
Q2 		$23.1M Buy
298,271
+11,721
+4% +$768K 0.01% 852
2015
Q1 		$16.6M Buy
286,550
+22,107
+8% +$939K 0.01% 1031
2014
Q4 		$8.53M Buy
264,443
+37,828
+17% +$1.14M 0.01% 1462
2014
Q3 		$5.54M Buy
226,615
+57,961
+34% +$1.18M ﹤0.01% 1699
2014
Q2 		$2.99M Buy
168,654
+6,331
+4% +$102K ﹤0.01% 2138
2014
Q1 		$3.25M Buy
162,323
+2,807
+2% +$54.4K ﹤0.01% 2047
2013
Q4 		$2.68M Buy
159,516
+26,918
+20% +$372K ﹤0.01% 2115
2013
Q3 		$1.41M Buy
132,598
+6,349
+5% +$55.5K ﹤0.01% 2387
2013
Q2 		$706K Buy
+126,249
New +$764K ﹤0.01% 2670

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Geode Capital Management's ANAC Position: Q2 2016 in Review

Geode Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 312,998 shares — an estimated $16.7K sold.

Geode Capital Management first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $35.2M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Geode Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Geode Capital Management sold 312,998 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $16.7K.
  • Geode Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Geode Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $35.2M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.